[HTML][HTML] Synergistic inhibition of glioblastoma multiforme through an in-silico analysis of luteolin and ferulic acid derived from Angelica sinensis and Cannabis sativa …

M Suhail, M Tarique, S Tabrez, TA Zughaibi… - PLoS One, 2023 - journals.plos.org
The primary objective of this study is to uncover novel therapeutic agents for the treatment of
Glioblastoma Multiforme (GBM), a highly aggressive form of brain cancer, and Alzheimer's …

[HTML][HTML] A random graph-based neural network approach to assess glioblastoma progression from perfusion MRI

H Ayaz, H Khosravi, I McLoughlin, D Tormey… - … Signal Processing and …, 2023 - Elsevier
The identification of glioblastoma progression from the non-contrast enhancing areas is
critically challenging to clinicians. This leads to poor prognosis and a very high local …

Enhancing plant-derived smart nano inhibitor in targeting mammalian target of rapamycin (mTOR) in breast cancer using Curcuma longa-derived compound …

AH Alamri, S Debnath, T Alqahtani, A Alqahtani… - … Science and Pollution …, 2024 - Springer
Breast cancer is a diverse female malignancy; its classification is based on clinical evidence
and pathological elucidation. Large public drug screening data databases combined with …

Molecular dynamics exploration of Lupenone: therapeutic implications for glioblastoma multiforme and alzheimer's amyloid beta pathogenesis

HM Almohaimeed, AI Almars, W Al Abdulmonem… - Metabolic Brain …, 2024 - Springer
Neuro-oncological and neurodegenerative disorders, represented paradigmatically by
glioblastoma and Alzheimer's disease, respectively, persist as formidable challenges in the …

Synthesis and computational insights of flavone derivatives as potential estrogen receptor alpha (ER-α) antagonist

BS Fegade, SB Jadhav, SY Chaudhari… - Journal of …, 2023 - Taylor & Francis
Hormone-related breast cancer is mostly caused by interactions with estrogen receptor
alpha (ER-α), which functions as a transcription factor to control the transcription of …